Targeting fibrosis: unraveling pathogenesis for therapeutic advances
Organ fibrosis constitutes the final common pathway of chronic progressive diseases, marked by excessive extracellular matrix (ECM) deposition, parenchymal cell loss, and structural disruption that culminate in organ failure across multiple tissues. Its pathogenesis is driven by dysregulated wound-healing responses t...